1 / 7

Pen Needles Market

The study segments Pen Needles industry in light of major classification such as product type, potential markets, application, and end-user.

RayMarchant
Download Presentation

Pen Needles Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pen Needles Market To Reach USD 2.48 Billion By 2026

  2. Market Summary Increasing elderly populations, rising incidence of obese-related diabetes, and a favorable reimbursement scenario are the key factors leading to the burgeoning growth in demand. Market Size – USD 1.43 Billion in 2018, Market Growth - CAGR of 7.3%, Market Trends – Growing incidence of diabetes. The global pen needles market is forecast to reach USD 2.48 Billion by 2026, according to a new report by Reports and Data. Pen needles are used for the drug administration for many diseases and are used by both healthcare professionals and patients themselves. They have become popularly accepted with the advancements in therapy and a supportive reimbursement structure in many nations. According to the World Health Organization (WHO), from 2015 to 2050, the aged population across the globe will be rise from 12% to 22% of the total global population. Owing to this, the incidence of target diseases such as chronic diseases and cancer is expected to grow and, in return, will boost the demand. An increase in healthcare expenditure across the globe also supports the adoption of user-friendly technologies. According to the American Diabetes Association, the annual healthcare cost in the U.S. increased by 26% during the last five years due to increased diabetes incidences. www.reportsanddata.com

  3. Further key findings from the report suggest • 4mm pen needles provide equal glycaemic control when compared to longer needles. 4mm pen needles have been shown to cause less pain as compared to longer needles, reduce any anxiety associated with injection, and provide an overall improved experience, which helps people with diabetes adhere more to an insulin injectable therapy program and also improves outcomes. • Retailer segment is primarily driven by consumers falling under the developing regions cohort. The rising cases of diabetes is a major driving factor for the manufacturers. Companies can tap into these unique market characteristics by building a robust distribution system based on retail sales. • The standard pen needles are used by the healthcare professionals as well as individual patients for injecting a variety of medications into the body. These pens are most commonly used by people with diabetes who often require multiple dosage of insulin injections daily.

  4. Market Summary Key Players: Becton, Dickinson and Co., B. Braun Melsungen AG, HTL-STREFA S.A., Terumo Corporation, Owen Mumford, Novo Nordisk A/S, Ypsomed Holding AG, Allinson Medical, Inc., Artsana S.p.a Segmentation: For the purpose of this study, Reports and Data have segmented the Pen Needles market on the basis of type, length, therapy, mode of purchase, and region: Type (Revenue, USD Million; 2016–2026) • Standard Pen Needles • Safety Pen Needles Length (Revenue, USD Million; 2016–2026) • 4 mm • 5 mm • 6 mm • 8 mm • 10 mm • 12 mm To look at the PDF Sample Report and get 30 minutes of a free consultation @ https://www.reportsanddata.com/sample-enquiry-form/2124 www.reportsanddata.com

  5. Market Summary Therapy (Revenue, USD Million; 2016–2026) • Insulin Therapy • Glucagon-Like Peptide-1 ((glp-1) Therapy • Growth Hormone Therapy • Others Mode of Purchase (Revenue, USD Million; 2016–2026) • Retail • Non-Retail Regional Outlook (Revenue in USD Million; 2016–2026) • North America • Europe • Asia Pacific • Middle East and Africa • Latin America Grab Your Report at an Impressive Discount! Please Click Here : https://www.reportsanddata.com/make-enquiry-form/2124 www.reportsanddata.com

  6. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com

  7. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related